Literature DB >> 17084759

Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.

Paul J Weidle1, Nafuna Wamai, Peter Solberg, Cheryl Liechty, Sam Sendagala, Willy Were, Jonathan Mermin, Kate Buchacz, Prosper Behumbiize, Ray L Ransom, Rebecca Bunnell.   

Abstract

BACKGROUND: Poverty and limited health services in rural Africa present barriers to adherence to antiretroviral therapy that necessitate innovative options other than facility-based methods for delivery and monitoring of such therapy. We assessed adherence to antiretroviral therapy in a cohort of HIV-infected people in a home-based AIDS care programme that provides the therapy and other AIDS care, prevention, and support services in rural Uganda.
METHODS: HIV-infected individuals with advanced HIV disease or a CD4-cell count of less than 250 cells per muL were eligible for antiretroviral therapy. Adherence interventions included group education, personal adherence plans developed with trained counsellors, a medicine companion, and weekly home delivery of antiretroviral therapy by trained lay field officers. We analysed factors associated with pill count adherence (PCA) of less than 95%, medication possession ratio (MPR) of less than 95%, and HIV viral load of 1000 copies per mL or more at 6 months (second quarter) and 12 months (fourth quarter) of follow-up.
FINDINGS: 987 adults who had received no previous antiretroviral therapy (median CD4-cell count 124 cells per muL, median viral load 217,000 copies per mL) were enrolled between July, 2003, and May, 2004. PCA of less than 95% was calculated for 0.7-2.6% of participants in any quarter and MPR of less than 95% for 3.3-11.1%. Viral load was below 1000 copies per mL for 894 (98%) of 913 participants in the second quarter and for 860 (96%) of 894 of participants in the fourth quarter. In separate multivariate models, viral load of at least 1000 copies per mL was associated with both PCA below 95% (second quarter odds ratio 10.6 [95% CI 2.45-45.7]; fourth quarter 14.5 [2.51-83.6]) and MPR less than 95% (second quarter 9.44 [3.40-26.2]; fourth quarter 10.5 [4.22-25.9]).
INTERPRETATION: Good adherence and response to antiretroviral therapy can be achieved in a home-based AIDS care programme in a resource-limited rural African setting. Health-care systems must continue to implement, evaluate, and modify interventions to overcome barriers to comprehensive AIDS care programmes, especially the barriers to adherence with antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084759     DOI: 10.1016/S0140-6736(06)69118-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  97 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

2.  Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications.

Authors:  Noah C Godwin; James H Willig; Christa R Nevin; Hui-Yi Lin; Jeroan Allison; Kathy Gaddis; Jennifer Peterson; Michael S Saag; Michael J Mugavero; James L Raper
Journal:  Health Serv Res       Date:  2011-01-06       Impact factor: 3.402

3.  Knowledge, attitudes, and practice of tuberculosis among Maasai in Simanjiro district, Tanzania.

Authors:  Pieter Jacob Haasnoot; Tijs Evert Boeting; Moignet Ole Kuney; Jos van Roosmalen
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

Review 4.  Impact of community-based support services on antiretroviral treatment programme delivery and outcomes in resource-limited countries: a synthetic review.

Authors:  Edwin Wouters; Wim Van Damme; Dingie van Rensburg; Caroline Masquillier; Herman Meulemans
Journal:  BMC Health Serv Res       Date:  2012-07-09       Impact factor: 2.655

5.  Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings.

Authors:  Kartik K Venkatesh; A K Srikrishnan; Kenneth H Mayer; N Kumarasamy; Sudha Raminani; E Thamburaj; Lakshmi Prasad; Elizabeth W Triche; Suniti Solomon; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2010-11-22       Impact factor: 5.078

Review 6.  Antiretroviral treatment strategies in resource-limited settings.

Authors:  Anna K Person; Habib O Ramadhani; Nathan M Thielman
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

7.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

Authors:  James H McMahon; Michael R Jordan; Karen Kelley; Silvia Bertagnolio; Steven Y Hong; Christine A Wanke; Sharon R Lewin; Julian H Elliott
Journal:  Clin Infect Dis       Date:  2011-01-18       Impact factor: 9.079

8.  Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals.

Authors:  Macarthur Charles; Francine Noel; Paul Leger; Patrice Severe; Cynthia Riviere; Carole Anne Beauharnais; Erica Miller; John Rutledge; Heejung Bang; Wesley Shealey; Richard T D'Aquila; Roy M Gulick; Warren D Johnson; Peter F Wright; Jean William Pape; Daniel W Fitzgerald
Journal:  Bull World Health Organ       Date:  2008-12       Impact factor: 9.408

9.  The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda.

Authors:  Elliot Marseille; James G Kahn; Christian Pitter; Rebecca Bunnell; William Epalatai; Emmanuel Jawe; Willy Were; Jonathan Mermin
Journal:  Appl Health Econ Health Policy       Date:  2009       Impact factor: 2.561

10.  Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Authors:  Norma C Ware; John Idoko; Sylvia Kaaya; Irene Andia Biraro; Monique A Wyatt; Oche Agbaji; Guerino Chalamilla; David R Bangsberg
Journal:  PLoS Med       Date:  2009-01-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.